Regeneron: Study Shows Its Monoclonal Antibody Cocktail Works Against Coronavirus Variants


Tests on two different variants of the coronavirus show that one of the two monoclonal antibodies in Regeneron's cocktail therapy can neutralize both, despite the mutations, researchers reported Wednesday.


The tests also confirm what other teams of researchers have found: vaccines are likely to protect people against both the variant first seen in Britain and known as B.1.1.7, and one first noted in South Africa and called B.1.135. However, the mutations in B.1.135 do allow the virus to evade immune responses a little more, the team, led by Dr. David Ho at Columbia University's Aaron Diamond AIDS Research Center, reported in a pre-print report -- one not yet published in a peer-reviewed journal.


Check out the article published by CNN right here.

0 comments